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Abstract
Chronic suppurative lung disease (CSLD) is characterized by the presence of a chronic wet or productive cough and
recurrent lower respiratory infections. The aim of this study was to identify features of innate, cell-mediated and humoral
immunity that may increase susceptibility to respiratory infections in children with CSLD. Because non-typeable
Haemophilus influenzae (NTHi) is commonly isolated from the airways in CSLD, we examined immune responses to this
organism in 80 age-stratified children with CSLD and compared their responses with 51 healthy control children. Cytokines
involved in the generation and control of inflammation (IFN-c, IL-13, IL-5, IL-10 at 72 hours and TNFa, IL-6, IL-10 at 24 hours)
were measured in peripheral blood mononuclear cells challenged in vitro with live NTHi. We also measured circulating IgG
subclass antibodies (IgG1 and IgG4) to two H. influenzae outer membrane proteins, P4 and P6. The most notable finding was
that PBMC from children with CSLD produced significantly less IFN-c in response to NTHi than healthy control children
whereas mitogen-induced IFN-c production was similar in both groups. Overall there were minor differences in innate and
humoral immune responses between CSLD and control children. This study demonstrates that children with chronic
suppurative lung disease have an altered systemic cell-mediated immune response to NTHi in vitro. This deficient IFN-c
response may contribute to increased susceptibility to NTHi infections and the pathogenesis of CSLD in children.
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Introduction
Bronchiectasis and chronic suppurative lung disease (henceforth
collectively termed CSLD) describe a syndrome of persistent or
recurrent respiratory symptoms predominantly characterized by
chronic productive or wet cough. CSLD is increasingly recognized
as an important chronic respiratory disorder affecting children [1–
4] and adults [5] globally and may represent a precursor to
bronchiectasis [1].
Non-typeable Haemophilus influenzae (NTHi) are Gram-
negative bacteria commonly associated with chronic upper and
lower respiratory disease. It is the dominant species isolated from
the lower airways of children and adults with chronic respiratory
symptoms [6–8]. However, NTHi is also a commensal organism in
healthy adults [9] and children [10] and as healthy adults and
children both develop antibodies against NTHi [11,12], the
relationship between host and bacterium and the transition from
commensal organism to pathogen is likely influenced by a complex
interaction of host and bacterial factors.
One such host factor identified as important in adults is the cell-
mediated immune response. Altered NTHi-specific cytokine
responses, including Th2-skewed cytokine profiles have been
reported in adults (.50 years of age) with established bronchiec-
tasis or COPD and impaired lung function [11,13]. However, it is
unclear whether these alterations were involved in disease
induction, or rather arose as a consequence of systemic
inflammation in adults with chronic, severe disease [14,15]. A
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study in children with milder disease of short duration may help
elucidate some of these unresolved issues.
In the absence of published data to explain the susceptibility of
some children to recurrent lower respiratory infections, we
characterized systemic immune responses to NTHi in children
with CSLD and healthy children. Our key outcome measures
included NTHi-specific cytokine profiles (24 hour and 72 hour) in
vitro and serum antibodies specific for the H. influenzae outer
membrane proteins (OMP) P4 and P6. In this study we describe
these profiles and identify key differences which may contribute to
an increased susceptibility to lower respiratory infections in
children.
Materials and Methods
Study population and sample collection
Eighty children (aged#10 years) undergoing chest computed
tomography (CT) scan and flexible bronchoscopy for suspected
CSLD (CSLD group) and 51 age-matched children without acute
infection or clinical history of respiratory or chronic illness (healthy
control, HC group) were prospectively recruited (2008–2011) from
the Royal Darwin Hospital (RDH), Darwin, Northern Territory
(NT), Australia.
All children in the study group were clinically stable (absence of
respiratory exacerbation) at the time of sample collection. Blood
and bronchoalveolar lavage (BAL) for clinical and research
investigations were collected at the time of intravenous access
(i.e. at the start of general anesthesia), prior to chest CT scan/
bronchoscopy. Clinical and socio-demographic data were col-
lected using standardized data collection forms. Routine clinical
investigations [1] were performed using the regional reference
laboratory (RDH) and subsequently two children were excluded
from analysis following a diagnosis of primary immunodeficiency
(final n= 80). Radiographic diagnosis of bronchiectasis was made
by the pediatric respiratory physician (AC). Haemophilus influen-
zae, Streptococcus pneumoniae and Moraxella catarrhalis culture
and identification were performed by our laboratory (diagnostic
threshold .104 CFU/ml [6]). Pseudomonas aeruginosa and
Klebsiella pneumoniae culture and identification were performed
by the diagnostic laboratory at the Royal Darwin Hospital.
Healthy controls (absence of a history of chronic respiratory,
other non-respiratory illness and no acute illness within 4 weeks)
were enrolled primarily through RDH elective surgery list. They
did not have the same clinical work up as the CSLD group
(including chest CT, bronchoscopy) as these investigations were
not clinically indicated for their procedure. Blood was collected
under the same conditions as described for the group with CSLD,
prior to any procedure. BAL was not collected from the control
children.
The Human Research Ethics Committee (Northern Territory
Department of Health and Menzies School of Health Research)
approved this study (#07/63). The children were enrolled
following written informed consent from the parent/carer.
NTHi preparation
A single NTHi strain originally isolated from the sputum of an
adult with pneumonia (confirmed by the Phadebact Haemophilus
Test (Bactus AB, Huddinge, Sweden) and by PCR [16]) was used
for this study. The immunogenicity of this strain and optimization
of culture conditions were first determined in peripheral blood
mononuclear cell (PBMC) cultures from healthy adults. A pilot
study of 19 additional NTHi strains indicated that the strain used
in this study was representative of NTHi-specific cytokine
responses in a healthy adult.
NTHi was grown on chocolate agar plates overnight at 37uC,
5% CO2. Brain heart infusion broth supplemented with hemin
(30 mg/L), nicotinamide adenine dinucleotide (30 mg/L) and
glycerol (4%) was inoculated with isolated colonies and incubated
with shaking at 37uC overnight. This starter culture was used to
inoculate a large volume broth culture and grown to an optical
density at 600 of 0.47 units. Single use aliquots were stored in 20%
heat-inactivated fetal bovine serum (FBS) at 280uC. The same
batch of NTHi was used in all experiments. Viability was
quantified by plating serial dilutions on chocolate agar and batch
viability was routinely monitored.
Peripheral Blood Mononuclear Cell (PBMC) isolation
Venous blood was collected into preservative-free heparin and
processed within 2 hours. PBMC were isolated by centrifugation
over Ficoll-Paque Plus (GE Healthcare Bio-Sciences AB, Sweden)
and cryopreserved in liquid nitrogen in 10%DMSO/heat-
inactivated FBS. These techniques have been successfully used
in studies of immune function in large human cohorts [17,18].
Matched plasma for antibody analysis was stored at 280uC.
PBMC challenge assays
In order to measure adaptive, cell mediated immune function,
PBMC were resuspended in AIM-V serum-free medium (Gibco
Life Technologies, Australia) supplemented with 2-mercaptoeth-
anol (0.04 mM final concentration), and cultured in duplicate at
2.56105 cells per well in 96 well plates with either live NTHi
(46106 CFU/ml final concentration), PHA (2 mg/ml; Sigma,
Missouri, USA) or medium alone for 72 hours at 37uC, 5%
CO2. IFNc, IL-13, IL-5 and IL-10 were measured in supernatant
collected at 72 hours. Where sufficient cells were available, innate
immune responses (IL-6, TNFa and early IL-10) were also
assessed. PBMC were cultured in RPMI 1640 with 10% non-heat
inactivated FCS and NTHi (46106 and 46105 CFU/ml final
concentration), or medium alone for 24 hours at 37uC, 5% CO2.
Supernatants were collected and stored at 4uC for up to 7 days
prior to cytokine quantification.
Quantification of cytokines
Cytokines were measured from the 72 and 24 hour culture
supernatants using dissociation-enhanced lanthanide fluorescent
immunoassays (DELFIA) as described previously [19]. Quantita-
tive standard curves were generated from serial dilutions of
recombinant human cytokine proteins and included on each plate.
The limit of detection for all cytokines was 10 pg/ml; samples with
concentrations below the limit of detection were assigned the value
of 1 pg/ml. The data is presented as delta concentrations (amount
of cytokine from NTHi challenge minus nil challenge). Children
were identified as responders if cytokine production was at least
two-fold greater than the nil treatment or two-fold above the assay
limit of detection (whichever was greater).
Immunoglobulin levels
IgG1 and IgG4 specific for the recombinant outer-membrane
proteins (OMP) P4 and P6 from H. influenzae were quantified
from plasma by Dissociation Enhanced Lanthanide Fluorescent
Immunoassay (DELFIA; PerkinElmer) as previously described
[20,21]. Negative control plasma for each OMP/antibody
combination were included on each plate. Plasma IgE was
measured using ELISA. Children were identified as responders if
their antibody level was at least two-fold greater than the mean
concentration of the negative control plasma.
NTHi-Specific Immune Responses in Children with CSLD
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Data analysis
For the primary analysis, the children were stratified by age (,
18, 18–36, 37–60 and .60 months) and the data analyzed
according to respiratory diagnosis (healthy control or CSLD). As a
secondary analysis, the age groups were combined and potential
confounding factors of the data identified and assessed in the
analysis. For the secondary analysis, only cytokines which
maintained a statistical difference following correction for poten-
tial confounding factors are described.
Statistical analysis was performed using STATA 13 (StataCorp,
USA) and a p-value ,0.05 was considered statistically significant.
Group differences (by age, diagnosis of CSLD and cultural
background) were assessed by the Mann-Whitney U test and
categorical data were assessed by Fisher’s exact test. Cytokine and
antibody data were non-parametric and are presented as median
with interquartile range. Potential factors that might confound
analysis of the immunologic data were identified (cultural
background, clinical characteristics) and regression analysis used
to investigate their effects.
Results
Study population
The demographic characteristics of the children are shown in
table 1. All of the children in the current study came from a
similar geographic region, northern Australia. High generational
cultural diversity is a characteristic of the population in this region
and studies to determine the influence of race on the immune
response are not feasible. Despite this, we found that a high
proportion of children in the CSLD group were identified by their
parent as having Indigenous Australian ancestry, thus we have
grouped children as either having known Indigenous Australian
ancestry (described as Indigenous descent) or with no, or
unknown, Indigenous Australian ancestry (non-Indigenous de-
scent).
Children with CSLD have altered 72 hour NTHi-cytokine
profiles
We detected IFN-c, IL-13 and IL-10 in the NTHi-challenged
PBMC culture supernatants from almost all children (figure 1a).
Whilst the number of IL-5 responders was comparatively low, the
CSLD group had almost 2-fold more responders than the HC
group.
For the three older age groups, PBMC from children with
CSLD produced significantly less IFN-c compared with HC
children but no significant difference between groups were present
in the,18 month age group (figure 1a). When all age groups were
combined, IFN-c production was also significantly lower in the
CSLD group compared to HC (median (IQR) 876 (145–2536)
versus 7861 (1939–17840) pg/ml, age-adjusted p,0.001; table
S1).
In the HC group there was a dramatic upward trajectory in
IFNc production between the ,18 month age group and the 18–
36 month age groups (median 845 versus 8115 pg/ml; p= 0.06)
and this level of production remained high in the older children. In
contrast, IFNc production in children with CSLD ,18 months of
age was similar to that seen in children with CSLD in the 18–36
month age group (median 928 versus 678 pg/ml; p = 0.36) and
also similar to that seen in the older age groups (figure 1b).
Furthermore, children with CSLD aged ,18 months produced
higher amounts of the Th2 associated cytokine IL-13 than the age-
matched HC children (median 63 versus 19 ng/ml; p = 0.03). In
contrast, IL-13 production was similar in CSLD and HC children
in each of the three older age groups. The production of IL-5 and
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Figure 1. Adaptive (72 hour) cytokine production to NTHi. a) In vitro cytokine production by HC (open circles) and CSLD (filled circles) PBMC
following 72 hour challenge with NTHi. Delta concentration (NTHi challenge minus nil challenge) with median and IQR. b) Trajectory of adaptive
(72 hour) IFN-c production to NTHi with age. In vitro cytokine production by HC (open circles) and CSLD (filled circles) PBMC following 72 hour
challenge with NTHi. Median (delta) concentration, pg/ml.
doi:10.1371/journal.pone.0104236.g001
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IL-10 did not differ between the CSLD and HC groups across any
age group.
We used the non-specific mitogen PHA to test the global
capacity for cytokine production and found minimal differences
between CSLD and HC children (figure 2). These data indicate
that the reduced capacity to synthesise IFN-c observed in CSLD
children aged .18 months is specific to NTHi and cannot be
attributed to a generalised impairment in the capacity of T-cell
and natural killer cells to produce these cytokines.
As CSLD was found to be prevalent in children of Indigenous
descent, we investigated if this contributed to the differences in
IFN-c observed between children with CSLD and HC children.
We found that Indigenous children with CSLD produced
significantly less IFN-c than age-matched Indigenous HC children
(median 703 versus 3497 pg/ml; p,0.001) and non-Indigenous
HC children (median 703 versus 10017 pg/ml p,0.001) (table 2).
Finally, using regression analysis, Indigenous descent was not an
independent predictor of IFN-c production (table S1).
Innate (24 hour) cytokine responses to NTHi
Because innate immunity may modulate adaptive immunity, we
examined the strength and nature of the innate immune response
to NTHi by measuring IL-6, TNFa and IL-10 production in
24 hour NTHi-stimulated PBMC (figure 3). Measurable quanti-
ties of the cytokines were produced by almost all children.
Children with CSLD aged18–36 months produced less IL-6 and
TNFa than HC children, but these differences were not observed
in the three other age groups. IL-10 production at 24 hours was
similar across all groups. When all age groups were combined, the
CSLD group produced less IL-6 than the HC group (median
(IQR) 5527 (3131–8733) versus11425 (4835–18458) pg/ml, age-
adjusted p= 0.007; table S1).
As found with the 72 hour cytokine data, none of the 24 hour
cytokine data varied in relation to Indigenous descent (table 2).
Serum antibodies specific for H. influenzae outer
membrane proteins P4 and P6
Most children had measurable serum IgG1 to both P4 and P6.
The number producing detectable levels of IgG4 was low. Only
minor differences were observed between the children with CSLD
and the HC children (figure 4).
Figure 2. Adaptive (72 hour) cytokine production to PHA. In vitro cytokine production by HC (open symbols) and CSLD (filled symbols) PBMC
following 72 hour challenge with the non-specific mitogen PHA. Delta concentration (NTHi challenge minus nil challenge) with median and IQR.
doi:10.1371/journal.pone.0104236.g002
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Effect of patient and clinical characteristics on cytokine
response
Although all children were clinically stable at the time of sample
collection, 45% were receiving maintenance antibiotics for CLSD
or chronic suppurative otitis media, a common co-morbidity in
this population. BAL culture showed lower airway infection
(growth of $104 colony-forming units (CFU)/mL of any pathogen
using standard culture methods) in 21 (25.6%) children. NTHi was
the most common pathogen identified (24% of children), followed
by Streptococcus pneumoniae (5%) and Moraxella catarrhalis (5%),
Pseudomonas aeruginosa (2.5%) and Klebsiella pneumoniae (1%).
Serum total IgE was similar between healthy controls (HC)
(median 449 ng/ml; IQR 73–1142 ng/ml) and the CSLD group
(641 ng/ml; 149–1623 ng/ml) (p = 0.07). All but one child were
up to date with their childhood vaccination schedule. Using
regression analysis, Mann-Whitney U test or Spearman’s rank
order correlation, we investigated whether these characteristics of
the children with CSLD at the time of sample collection could
explain variations in NTHi-induced cytokine production. The
observed NTHi-stimulated cytokine responses were not associated
with antibiotic use (including azithromycin), current isolation of
NTHi or other respiratory pathogens in the BAL, evidence of
parasitic infection (strongyloides), serum IgE and inflammatory
cell counts in BAL and blood (table S2).
Discussion
Despite advances in the prevention and management of
pediatric respiratory infections, CSLD remains a problem in
children and adults globally. This prospective, cross-sectional
study is the first to compare NTHi-driven innate, cell-mediated
and humoral immune responses across a large group of children
with CSLD (n= 80) and healthy control children (n= 51). The
most notable finding was that, in children aged $18 months,
PBMC from those with CSLD produced significantly less IFN-c
than PBMC from their healthy peers. In contrast, in children aged
,18 months, those with CSLD produced more IL-13 than the
healthy control children. We found comparatively minor differ-
ences in humoral and innate immune responses. These data are
consistent with our hypothesis that impaired cell mediated
immune responses may contribute to the pathogenesis of CSLD
in children.
Immune development begins in utero [22,23]. Various envi-
ronmental, respiratory and immune pressures drive the matura-
tion of the Th1 response from the Th2-dominated response of
neonates [24–26]. By 18 months of age there is a substantial rise in
IFN-c function [27] and a delay in the development of the IFN-c
response may predict Th2-associated disorders in childhood [28].
IFN-c, primarily secreted by T lymphocytes and natural killer
cells, is integral to the orchestration of antiviral and antibacterial
activity and is a dominant Th1 cytokine. Furthermore impaired
IFN-c responses have been implicated in the pathogenesis of
rhinovirus-induced asthma exacerbations in adults [29]. Whilst
our study was not designed to investigate the mechanistic process
of immune maturation, our findings have highlighted a disparity
between children with CSLD and HC children in age-related IFN-
c and IL-13 production. We found a log-fold increase in IFN-c
production between HC aged ,18 months compared to those .
18 months. The capacity to produce IFN-c remained high in the
older age groups. These data are consistent with normal
maturation of the Th1 response through early childhood. This
age-related increase in IFN-c response observed in the HC
Table 2. Cytokine production (pg/ml; median (IQR)) from NTHi-challenged PBMC from children $18 months; HC Indigenous
descent n = 15, HC non-Indigenous descent n = 30, CSLD Indigenous descent n = 60, CSLD non-Indigenous descent n = 2.
Indigenous descent non-Indigenous descent p#
IFN-c (72 hr) HC 3497 (1939–33950) 10017 (3331–24437) 0.36
CSLD 703 (102–2190) 557, 3858** n/a*
p## ,0.001 n/a*
IL-13 (72 hr) HC 44 (37–123) 46 (25–66) 0.36
CSLD 65 (33–129) 50, 69** n/a*
p## 0.76 n/a*
IL-5 (72 hr) HC 0 (0–37) 0 (0–3) 0.07
CSLD 7 (0–40) 0, 9** n/a*
p## 0.54 n/a*
IL-10 (72 hr) HC 562 (352–1454) 1336 (555–2230) 0.03
CSLD 682 (279–1109) 391, 467** n/a*
p## 0.83 n/a*
TNF (24 hr) HC 656 (541–1094) 1556 (727–2086) 0.10
CSLD 588 (226–1267) 181, 533** n/a*
p## 0.53 n/a*
IL-6 (24 hr) HC 7154 (4221–18458) 12819 (8966–17698) 0.18
CSLD 6563 (3701–10969) 2304, 2736** n/a*
p## 0.38 n/a*
#Analysis between Indigenous and non-Indigenous descent.
##analysis between HC and CSLD.
*p value not calculated due to small numbers.
**absolute values for the 2 participants.
doi:10.1371/journal.pone.0104236.t002
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children was not reflected in the children with CSLD. Children ,
18 months of age with CSLD had a similar capacity for NTHi-
specific IFN-c production as their HC peers, however unlike the
HC group, the CSLD group maintained a significantly lower
capacity for IFN-c production over subsequent increasing age
groups. Conversely, IL-13 production was significantly higher in
younger children with CSLD, with no significant difference
between the two groups in older children. Whilst future
longitudinal studies are required, these data support the notion
that normal maturation of the cell mediated immune response is
impaired in children who develop CSLD.
We also examined cytokines representative of innate immune
responses in PBMC challenged for 24 hours with NTHi reasoning
that altered innate immunity might provide a mechanism for
altered adaptive immunity. No studies have previously addressed
this issue in children with CSLD. IL-6 is an important cytokine in
facilitating the transition from the innate to the adaptive response
and is also important for the resolution of acute inflammation
(reviewed in Jones [30]). The low IL-6 response to NTHi which we
observed in children with CSLD as a group and in the 18–36
month age group is consistent with our data demonstrating an
impaired cell-mediated immune response. That TNFa production
was also low in 18–36 month CSLD children may point to an
immaturity or impaired function of innate immune cells such as
monocytes or dendritic cells. Immaturity of such antigen
presenting cells would also account for low IFN-c responses to
antigenic stimulation via impaired IL-12 or IL-27 pathways [31].
The possible contribution of IL-6 and other Th1-polarising
cytokines, including IL-12 and IL-27, to the pathogenesis of
NTHi infections and chronic inflammation requires exploration in
future longitudinal studies.
P4 and P6 are highly conserved, immunogenic outer membrane
proteins ubiquitously expressed on H. influenzae. Given the
association of OMP antibodies with protection from NTHi
infection in animal models [32] and the association of low P4
and P6 IgG1 titres with asthma and atopy, in children [20], we
investigated if children with CSLD were deficient in NTHi-specific
antibodies, especially since clinical investigations found no
deficiency in total IgG or any IgG subgroup overall. Consistent
with published data [20,21], most children in our study produced
IgG1 to P4 and P6 whilst the number of children (CSLD and HC)
producing IgG4 to either antigen was low. In contrast to published
Figure 3. Innate (24 hour) cytokine production. In vitro cytokine production by HC (open circles) and CSLD (filled circles) PBMC following
24 hour challenge with NTHi. Delta concentration (NTHi challenge minus nil challenge) with median and IQR.
doi:10.1371/journal.pone.0104236.g003
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data of children with Th2-associated disorders asthma and atopy
[20] we found no significant difference in P4 and P6 IgG1 levels
between children with CLSD and HC children. These results plus
the comparable levels of early (24 hour) and later (72 hour) IL-10
responses support the hypothesis that non-protective immunity to
NTHi in children with CSLD is more closely linked to aberrant
cell-mediated immune function rather than the humoral arm of
the immune response.
Our finding that children with CLSD have an impaired IFN-c
response to NTHi has some interesting parallels with that
described in adults with the chronic respiratory conditions
associated with infection (COPD and bronchiectasis). In these
studies involving smaller cohorts, King and colleagues demon-
strated that persistent or recurrent lower respiratory infection with
NTHi in adults with COPD (n= 39) or bronchiectasis (n = 16) was
associated with high IL-13 production in the airways and low
systemic IFN-c production [13,11]. These studies provide
important data on the pathogenesis of NTHi infection in adults,
however extrapolation of this data to the pediatric setting may not
be appropriate. The strengths of our study, which also distinguish
it from the adult studies, lie in our large sample size of young
children with early onset chronic disease. 75% of our total cohort
(n = 80) were aged ,3.5 years and had comparatively mild disease
of recent onset. The effect of age, chronic inflammation, airway
remodeling and pollutants on immune responses is well docu-
mented [33–36]. Thus studying CSLD in children with early stage
disease may be more instructive to understanding the early
pathogenesis of bronchiectasis. The differences in immune
function described in the current study are more likely to be
involved in disease initiation rather than an effect of chronic
disease and long standing tissue damage.
It is now evident that the airways are colonized with microbial
flora and that respiratory illness is frequently characterized by
changes in the normal microbiota [9]. Furthermore emerging
evidence suggests that normal immune profiles vary between
populations; children from regions of high pathogen burden have
functionally distinct immune profiles compared with children from
regions of low burden [23,24]. Whilst all of the children in our
study came from a similar geographic location, a large proportion
of our CSLD group identified with an Indigenous Australian
ancestry. Many factors beyond the scope of this study may
contribute to this disparity including both biological and socio-
economic determinants of health. We undertook several ap-
proaches to ensure that the differences in cytokine profiles were a
result of the CSLD and not merely explained by the demographics
of the population.
Figure 4. Serum IgG1 and IgG4 to outer membrane proteins P4 and P6. HC (open circles) and CSLD (filled circles). Concentration with
median and inter-quartile range.
doi:10.1371/journal.pone.0104236.g004
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There are numerous host and environmental factors which may
influence the immune response thus, whilst our current study has
novel findings, we acknowledge some limitations. We chose to use
NTHi because it is the most common bacterium in children with
CSLD but it was beyond the scope of our study to examine if other
pathogens also induce low IFN-c responses. Secondly it is a cross-
sectional study thus we cannot explain the cause or the effect of the
observed impaired IFN-c response in children with CSLD. Also,
the association between systemic and local airway responses is
unknown as limited cell numbers obtained from BAL precluded
measurement of IFN-c production by airway T-cells in our study.
Nonetheless, our findings suggest that altered systemic immune
responses are characteristic of CSLD, and we would argue that
both local and systemic immunity are likely to be important in
defending the lungs from respiratory pathogens.
In conclusion, this is the first study to compare NTHi-driven
innate, cell-mediated and humoral immune responses between a
large group of children with CSLD and HC children. Our key
finding is that the ability to induce protective cell mediated
immune responses against NTHi is compromised in children with
CSLD. We found clear evidence of impaired IFN-c responses by
PBMC, in vitro, in children with CSLD and limited evidence of
impaired innate and humoral responses. Furthermore, whilst our
data on young infant responses is preliminary it suggests that this
impairment begins at an early age. This study has important
implications for research into management strategies for children
at risk of CSLD. Effective management strategies require an
understanding of host responses to respiratory pathogens and the
contribution of these responses to the pathogenesis of chronic
infection. Future intervention studies that can improve cell
mediated immune responses along with longitudinal studies
examining the relative contributions of delayed immune develop-
ment, and high microbial load to the pathophysiology of CSLD in
children, are required.
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